Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach

PLoS One. 2013;8(2):e56246. doi: 10.1371/journal.pone.0056246. Epub 2013 Feb 13.

Abstract

Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory joint disease with a poorly understood etiology. Despite widespread diagnostic use of anti-citrullinated protein antibodies and rheumatoid factor proteins there is a strong demand for novel serological biomarkers to improve the diagnosis this disease. The present study was aimed to identify novel autoantigens involved in rheumatoid arthritis (RA) pathogenesis through immune-proteomic strategy. Synovial fluid samples from clinically diagnosed RA patients were separated on two-dimensional gel electrophoresis (2-DE). Samples from patients with non-RA rheumatisms (osteoarthritis and trauma) were used as controls. Immunoreactive proteins were spotted by Western blotting followed by identification through Q-TOF mass spectrometer analysis. Forty Western blots were generated using plasma from ten individual RA patients and 33 reactive spots were identified, 20 from the high molecular weight (HMW) gel and 13 from the low molecular weight (LMW) gel. Among the 33 common immunogenic spots, 18 distinct autoantigens were identified, out of which 14 are novel proteins in this context. Expression analysis of five important proteins, vimentin, gelsolin, alpha 2 HS glycoprotein (AHSG), glial fibrillary acidic protein (GFAP), and α1B-glycoprotein (A1BG) by Western blot analysis using their specific antibodies revealed their higher expression in RA synovial fluid as compared to non-RA samples. Recombinantly expressed GFAP and A1BG protein were used to develop an in-house ELISA to quantify the amount of autoantibodies in the RA patients. RA patients revealed an increase in the expression of GFAP and A1BG in the plasma as compared to osteoarthritis patients. Therefore, GFAP and A1BG can be proposed as potential new autoantigens of diagnostic importance for RA subjects. Further characterization of these proteins in rheumatoid arthritis will be helpful in understanding the role of these proteins in the disease pathogenesis providing new diagnostic tool with better specificity and accurate detection of the disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Amino Acid Sequence
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / immunology*
  • Arthritis, Rheumatoid / metabolism
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Autoantigens / analysis
  • Autoantigens / immunology*
  • Blotting, Western
  • Electrophoresis, Gel, Two-Dimensional
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gelsolin / analysis
  • Gelsolin / immunology
  • Glial Fibrillary Acidic Protein / analysis
  • Glial Fibrillary Acidic Protein / immunology
  • Glycoproteins / analysis
  • Glycoproteins / immunology
  • Humans
  • Immunoglobulins / analysis
  • Immunoglobulins / immunology
  • Male
  • Mass Spectrometry
  • Middle Aged
  • Molecular Sequence Data
  • Osteoarthritis / blood
  • Osteoarthritis / immunology
  • Osteoarthritis / metabolism
  • Proteomics / methods*
  • Synovial Fluid / chemistry
  • Synovial Fluid / immunology*
  • Vimentin / analysis
  • Vimentin / immunology
  • alpha-2-HS-Glycoprotein / analysis
  • alpha-2-HS-Glycoprotein / immunology

Substances

  • A1BG protein, human
  • AHSG protein, human
  • Autoantibodies
  • Autoantigens
  • Gelsolin
  • Glial Fibrillary Acidic Protein
  • Glycoproteins
  • Immunoglobulins
  • Vimentin
  • alpha-2-HS-Glycoprotein

Grants and funding

Financial assistance has been provided partly by Indian Council of Medical Research, Council of Scientific and Industrial Research, New Delhi, India, and Department of Clinical Chemistry, University Medical Center, Goettingen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.